LATEST
Falcons name Tua as Week 1 starter over Penix✦Week 1 overreactions: LSU is back! Michigan has issues! The ACC is a blast!✦Projecting the CFP top 12 after Week 1: Marathon opening slate sets up massive Week 2✦Mint Explainer | The post-Tim Cook Apple: Can John Ternus fill the big shoes?✦Prospects for trilateral negotiations on Ukraine, visit of US emissaries: Kremlin briefing✦
Mon, Sep 7, 2026
Loading weather...
Markets

HRV Pharma bets ₹150 crore on peptides, high-potency oncology APIs

The investments mark a shift in HRV’s seven-year-old business model—from using available manufacturing capacity to underwriting specialised capacity for products it owns and commercializes

By Dhallo News · September 7, 2026 at 5:22 PM IST
HRV Pharma bets ₹150 crore on peptides, high-potency oncology APIs
Source: Mint - Companies

The investments mark a shift in HRV’s seven-year-old business model—from using available manuf

acturing capacity to underwriting specialised capacity for products it owns and commercializes

SOURCE: Mint - Companies
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Mint Explainer | The post-Tim Cook Apple: Can John Ternus fill the big shoes?

Straight off, Apple’s new head will have a few burning questions to address....

Read Article »

Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth

Latest report from Yahoo Finance...

Read Article »

Jakarta airports remain closed for 2nd day after volcanic eruptions

Latest report from Nikkei Asia...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.